According to Vigil Neuroscience's latest financial reports the company has $0.10 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.18 B | 104.12% |
2021-12-31 | $91.42 M | 278.54% |
2020-12-31 | $24.15 M |